Personal Finance ($39 for the first year) is a relative low cost “entry level” investment newsletter, the kind that all the big publishers use to recruit the wave of new subscribers who get fed into their marketing “funnel” that generates leads for their higher-priced services… though, to be fair, we also often hear from readers […]
Articles
Today we’ve got a bit of a quickie for you, mostly just because the clues that were dropped were extremely limited… but it also happens to be a stock I’ve looked at before, so I thought it was worth taking a second look today. Paul Mampilly over the weekend was peddling his True Momentum service […]
Well, we finish out the week with yet another dramatic performance from the market-dominating tech stocks. Alphabet (GOOG) did better than expected and popped a bit, climbing further through the day, almost as much as the gains Microsoft (MSFT) made on a more dramatic ‘beat’ of expectations (though analysts have always been better at estimating […]
I’ve already shared the major portfolio change I made this week, adding that IPO to my Real Money Portfolio yesterday, and I have also separately posted my notes and thoughts from the CNBC Delivering Alpha conference for my favorite people (yes, that’s you!)…. but I have a couple other things to note as well, so […]
I have one relatively substantial portfolio change that I telegraphed to you last week, and which has been spurred by a recent dip in one stock and good news from another. I have sold about two thirds of my position in AIG 2021 Warrants following the trigger of a stop loss in that position (because […]
These kinds of ads always include some huge numbers that sound really, really impressive… here’s a little bit of the intro from the latest ad for Briton Ryle’s The Wealth Advisory: “*Jim T. collected $23,500 last month from ‘backdooring’ Google’s Account *Ron J. ‘backdoored’ $15,804 from Facebook’s Account *Aaron K. pocketed $6,817 last month from […]
This article originally appeared on January 24, 2017. It has not been updated. This ad has generated quite a few questions from Gumshoe readers, and I’ll agree that it sounds pretty enticing (of course, almost all ads do — that’s why they work so well!)… here’s part of the Jim Pearce email that gets the […]
Seriously? Google’s obligated to pay you every month? Well, kind of. But no, not really. This teaser pitch came in from Briton Ryle and the Angel Publishing folks a few times over the past week as they’ve been advertising The Wealth Advisory… and you might be thinking that it sounds kinda familiar. I thought so […]
We’re breaking things up a little bit today for the Friday File — this piece is about some investments that interest me personally, and I’ve also got a teaser solution piece for the Irregulars today that you can see here. The investments that are most appealing to me right now are both in the technology […]
As we enter mid-February and a slow week in Gumshoeland next week, I’ve got a few personal buys of stocks that we’ve mentioned before, and a new “Idea of the Month” candidate that’s maybe not quite ready to buy just yet (we’ll be closed on Monday, and will probably publish less than usual during the […]
This is just silly. Politicians always find their names appropriated by newsletter ad campaigns, because it’s an easy way to catch your eye — you’re already (or maybe not you, but lots of folks) feeling passionate about Donald Trump, or Hillary Clinton, or President Obama or whoever… so if those names are blazoned across an […]
[unlocked for free readers on October 7, 2015] Did you notice that Dr. Kent Moors is out again with his “trade has hit green light status” teaser pitch for his Energy Inner Circle newsletter? The ad is about an options trade he’s recommending on the US Oil ETF (USO), and we wrote about it back […]
I don’t have a single idea that makes me want to jump up and down this month — I’ve been trickling more money into Pershing Square Holdings (PSH.AS, PSHZF) and Tekla Healthcare (THQ) as well as more boring broad index funds and such, and have been tempted by some other investments, but nothing jumps out […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
In the end, what has happened to the effect on the Alzheimer's disease by this Promind Complex? Was it not the purpose o...
Are the results of the UCLA study for the bioavailable curcumin product better than those for Alzheimer's drugs?...
ACW.asx Actinogen presents latest Xanamem data at AD Conference https://actinogen.com.au/asx-announcements/ Above is l...
$INND Innerscope Hearing Technologies, Inc. Good to hear from you Wfuiii. I've nibbled again. There will be further...
$INND Innerscope Hearing Technologies, Inc. https://www.innd.com/ MarkeTrak 10: Hearing Aids in an Era of Disruption ...
https://assets.boardroom.media/company_logo/ccdd47bd-38a1-4648-a771-398f23d727eb.jpg $ACW.asx Actinogen Medical > ...
Thank you Michael for this refresher, update and all your very informative articles. Announced this article on Twitter...
The two leading world experts on Alzheimers are Dr Dale Bredesden who has written a book entitled 'The End of Alzheimers...
This was immensely interesting as my mother has Alzheimer’s. You do not mention anywhere the research carried out by D...
Prevention is much more effective that treatment. Other measures include exercise, eating little or no sugar and doing m...
Four years ago, we returned to our retirement home, purchased over 40 years previously. Going to greet our neighbors, w...
Please look at Anavex Life Sciences: AVXL as I believe that they are on the right track with their A2-73 drug candidate ...
You might want to have a look at AVXL. From today's MT Newswires: "07:42 AM EDT, 10/02/2019 (MT Newswires) -- Anavex Li...
Virtual reality can spot navigation problems in early Alzheimer's disease by University of Cambridge https://medicalxpr...
Fred, sorry I missed your comment on L-serine. Have you found another source that taste's ok/better? I have not found...
Another failure in Alzheimer's Disease trials... BIIB and Eisai discontinued their late Phase 3 trials because they were...
This is a business there will he sales nonsense and I looked before I bought in bought in about their opt out policy. Th...
What is Ray Blonco's "Alzheimer’s Disease cure" 4olbear....
Anybody with experience using L-serine for preventative for ALS Alzheimers?; I can not find on retail market. I read an...
There may be something behind this. A 2017 book "The End of Alzheimer's..." published by Penguin/Random House, written b...
#86AD > Mandelblatt cautioned that her study was still too small to reach any conclusion, but if future studies could re...
I hope it works well for you, and that their drug is both effective and profitable. I've gotten very skeptical about Al...
Hello Doc, All, I have hesitated to mention this company involved in this field, but since we are on a common thread, na...
Many interesting comments in response to that Alzheimer’s piece. I’ll try to respond to as many as I can. And ma...
Hi Doc. What do you think about ANAVEX ? They are starting a phase 3 and here are the recent bullets. One huge positive ...
What does running do to your #brain? https://pbs.twimg.com/media/DhHfG2ZWAAYz_xC.jpg ty https://twitter.com/LEAD_C...
New development in 3-D super-resolution imaging gives insight on Alzheimer's disease https://phys.org/news/2018-07-d-su...
$AXSM > Bid 204K at $3.05 Axsome Therapeutics Announces AXS-05 Presentation at the 2018 Alzheimer's Association Interna...
Yet More Evidence that Viruses May Cause Alzheimer's Disease https://gizmodo.com/yet-more-evidence-that-viruses-may-cau...
Excitement about Alzheimer's drugs sometimes spurs big movements in Phase 1 and 2, though so far almost all of them have...
I'm trying to assess the opportunity for an investment in Promis Neurosciences. They are a pre-clinical stage biotech co...
$VTVT np - vTv Therapeutics Inc. has added a news release to its Investor Relations website. Title: vTv Therapeutics ...
$VTVT np - vTv Therapeutics Announces Topline Results from the First STEADFAST Phase 3 Study Evaluating Azeliragon in Pe...
See research at Paul H. Duray Pathology Research Fellowship that show borrelia burgdorferi aka Lyme disease spirochetes ...
Dysregulation of the epigenetic landscape of normal aging in Alzheimer’s disease https://www.nature.com/articles/s415...
$ORY.BME - Oryzon to present at upcoming international conferences Madrid, Spain and Cambridge, MA - February 21st 20...
#AD - Arthritis drugs could halve the risk of Alzheimer's disease, study suggests http://www.telegraph.co.uk/news/2018/...
#AD - PMN.to NP - As someone who lost their father to alzheimer's disease, I did a fair bit of research into this compan...
$CWBR #MDPs New research article published in the journal of Alzheimer’s and Dementia supports a mitochondria(MDP)-b...
#AD #Tunes Another joy to parents/patients with Alzheimer's Disease is playing/listening to their favorite #music. Some...
Yep, there is a very wide gulf separating "Alzheimer’s Disease is Now Completely Treatable”" and "could give hope to...
#Alzheimer's Disease $CWBR Article: Dementia Shown Associated with Synaptic Dysfunction Rather Than Synaptic Loss GEN N...
Question of the week Maybe a bit of a trick question? My quick research says that the answer is HDV. It also says t...
NTRP-NP. Looking for $6.55 ( untested low) for SP. I am surprised that there hasn't been more interest in this outfit. R...
$AXSM UW Axsome announces recommendations to continue COAST-1, discontinue CREATE-1 trial Axsome Therapeutics an...
#Alzheimers Disease $Biogen$Merck$J&J$Denali Nice summary article in WSJ "Drug Industry Isn't Giving Up On Alzheimer's" ...
TRAVIS, LYNN, #ZKSS one in Moderation replaced by this one... #Alzheimer's #Disease #AD… The Neuroscience Inno...
$NTRP np - https://www.morningstar.com/news/pr-news-wire/PRNews_20171219NY73157/neurotrope-to-present-additional-findin...
$NTRP (long) [Post-hoc subgroup analysis of Phase 2 patients, completed May 2016, shows that Bryostatin had an appare...
$PFE Pfizer Ends Hunt for Drugs to Treat Alzheimer’s and Parkinson’s - About 300 layoffs to take place after once...
$Alzheimer Hi John, scary indeed. Last I heard the role of tau-phosphorylation in the pathogenesis of Alzheimers Dis...
$Alzheimers $AD (A great read of new research findings) Alzheimer’s protein may spread like an infection, human...
#Alzheimer'sDisease - Healthy mitochondria could stop Alzheimer's Date: December 6, 2017 Source: Ecole Polytechnique F...
#Alzheimer's Disease related - How Loneliness Affects Our Health https://www.nytimes.com/2017/12/11/well/mind/how-lonel...
Grief is convoluted but does have two "messy" phases: LOSS -as you plunge into a pit of pain and confusion, and then, ...
#Alzheimer's Disease related - http://fortune.com/2017/12/01/human-longevity-dna-ceo-out/...
#Alzheimer’s Disease Protective Alzheimer’s Gene Variant Uncovered ---> Linkage, whole genome sequence, and biologi...
#Alzheimer's Disease Protective Alzheimer's Gene Variant Uncovered https://genomemedicine.biomedcentral.com/articles/10....
Michael Jorrin - This was posted on the ihub message board this morning. This is too lengthy for your comment section bu...
My research into Alzheimer’s potential “cures” or drugs that do not attack the disease from the amyloid plaque ang...
What do you think about "Anavex Life Sciences Says Study of ANAVEX2-73 Shows Improvement in Alzheimer's Disease Patients...
Are you aware of the work by Dr Dale Bredesen? Here is a summary of that work as reported by Dr Mercola on his website:...
$ AXSM NP : (AXSM) More News 08-Nov-2017:07:00:00, Axsome Therapeutics Reports Third Quarter 2017 Financial R...
$Anti-aging $Mitochondria (?) An exciting new research report from NATURE (11/1) “Infusions of young blood tes...
$AXON np #FAIL Announces Negative Topline Results of Intepirdine Phase 3 MINDSET Trial in Alzheimer's Disease http:/...
$AXON -- I wish I had the guts to short this. Interesting piece on Alzheimers but doc is embargoed 'til December. Long-...
#Alzheimer's_Disease - $BIIB - Biogen Reports New Data from Phase 1b Study of Investigational Alzheimer’s Disease Trea...
#Alzheimers _Hypothesis “Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer’s Disease.” St...
#Alzheimers _Hypothesis “Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer’s Disease.” St...
$Alzheimers $Hypothesis "Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer's Disease." Sternb...
I wrote today about a different Alzheimer's Disease drug being tested in mice, not the one Doc Gumshoe mentioned. It als...
$AXSM long - Prognosticating report and update tomorrow, Aug 9th, as that was the date last year. http://finviz.com/qu...
Molecular link between post-traumatic stress disorder and Alzheimer's disease https://medicalxpress.com/news/2017-08-m...
Interesting article. This seems to support the positive affect of Doxycycline for AD as it passes the BBB easily. A tria...
$NTRP Neurotrope Presents Phase 2 Data Assessing Bryostatin-1 in Moderate-to-Severe Alzheimer's Patients at AAIC 201...
$AXSM long - Title: Axsome Therapeutics Initiates Phase 2/3 Trial of AXS-05 for Alzheimer's Disease Agitation http://...
$Diabetes $Obesity $Alzheimers Disease "Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disea...
Scientists uncover the structure of tau filaments from Alzheimer’s disease https://medicalxpress.com/news/2017-07-atom...
Scientists uncover the structure of tau filaments from Alzheimer's disease https://medicalxpress.com/news/2017-07-atomic...
$CUR np - Neurotrope to Present Bryostatin Phase 2 Data in an Oral Presentation at AAIC 2017 Meeting NEW YORK - June 29...
#Alzheimer's Prevention - interesting new findings published in Medscape "Olive Oil Key Ingredient in Alzheimer's Pre...
#Alzheimer's Prevention - interesting new findings published in Medscape "Olive Oil Key Ingredient in Alzheimer's Pre...
#Alzheimer's Prevention - interesting new findings published in Medscape "Olive Oil Key Ingredient in Alzheimer's Pre...
I think folks have tired of the constant promise -- AVXL has been pitched as an "Alzheimer's Cure" company for almost a ...
$EBIX long and OW (but not like $AUPH!) This is the stock that got away from the Fool. I can't believe they never res...
They'd certainly like to believe they are. Anavex's drugs have been overpromised so many times over the years that I gr...
No $ticker. For those who have loved ones suffering from Alzheimer’s Disease, as I do, perhaps this is an alternative ...
Where to I go for Number 3. 3.A weird-looking mushroom from Europe that can REVERSE the effects of Alzheimer’s Disease...
$AXSM - Axsome Therapeutics Receives FDA Fast Track Designation for AXS-05 for Alzheimer's Disease Agitation Globe News...
$NTRP: Neurotrope Alzheimer's Trial Shows Top Line Efficacy in Hardest to Treat Patients Accesswire May 2, 201 Re...
$NTRP phew! glad you posted that Dr KSS. It's down pre-mkt but coming nicely off the bottom since you posted. Neurotr...
$NTRP Long Neurotrope Bioscience to Release Results From Phase 2 Clinical Trial in Moderate to Severe Alzheimer's Disea...
$AXSM: Initial AXS-02 Phase 3 trial data readout expected in 4Q17. AXS-02 is in Phase 3 development with Fast Track stat...
$TDSGF - 3D Signatures’ TeloView™ Software Identifies and Stages Patients With Alzheimer’s Disease From a Cheek Sw...
Interesting and well written article. Thank you. It's particularly disturbing how little progress modern medicine has ...
I heard back from the Alzheimer’s foundation I donate to about the bexarotene study: "To summarize the results from wh...
Sometime back I was reading an article which mentioned an executive (can't remember the name) who had previously been at...
$NTRP The market does not seem too excited by the news out today, no change in stock price. I recall there are at least ...
Myron are you seriously calling Alzheimer's Disease a "lifestyle disease" caused by a lousy diet?? You claim that folk ...